Hongxi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hongxi Wang has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Binyao Chen
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong, China
6 shared publications- Mingzhi Zhang
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong, China
6 shared publications Jiao Jiang
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong, China
5 shared publications- Kunliang Qiu
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong, China
5 shared publications Xin Tan
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong, China
5 shared publicationsKunliang Qiu
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou, Guangdong, China
4 shared publications
Latest Publications
- 20 July 2026
- Published by BMJ in British Journal of Ophthalmology
Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes
Background and aims: The current study aims to investigate how age, period and cohort effects have shaped the patterns of diabetic retinopathy-related vision loss globally, distinguishing between loss associated with type 1 versus 2 diabetes. Methods: A secondary analysis of data from the Global Burden of Disease (GBD) 2021 study was conducted by using estimates of blindness and vision loss due to DR across different socio-demographic index (SDI) categories. Age-standardised prevalence rates, relative percentage changes, net drift and local drift were analysed. Findings: Globally, age-standardised prevalence (ASPR) of diabetes-related blindness and vision loss rose from 48.8 per 100 000 in 1990 to 67.3 per 100 000 in 2021, with type 1 diabetes-related blindness and vision loss ASPR showing a modest decrease (from 1.8 to 1.7 per 100 000). The highest relative increase was recorded in the high SDI group (45.8%). For Type 1 diabetes, low-middle and low SDI groups exhibited more pronounced declines in associated ASPR. Increasing ASPR with advancing age was consistent across SDI groups though less pronounced for type 1 than type 2 diabetes. Unfavourable period and cohort effects were observed for type 2 but not type 1-related blindness and vision loss risk. High-middle SDI and middle SDI groups showed the most notable increase in period and cohort effect, whereas low-middle and low SDI groups experienced favourable period and cohort risks during the study duration. Conclusions: Substantially different trends were observed for ASPR, period and cohort effects in recent decades for type 1 versus type 2 diabetes across different SDI.
- 20 July 2026
- Published by BMJ in British Journal of Ophthalmology
Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes
Background and aims: The current study aims to investigate how age, period and cohort effects have shaped the patterns of diabetic retinopathy-related vision loss globally, distinguishing between loss associated with type 1 versus 2 diabetes. Methods: A secondary analysis of data from the Global Burden of Disease (GBD) 2021 study was conducted by using estimates of blindness and vision loss due to DR across different socio-demographic index (SDI) categories. Age-standardised prevalence rates, relative percentage changes, net drift and local drift were analysed. Findings: Globally, age-standardised prevalence (ASPR) of diabetes-related blindness and vision loss rose from 48.8 per 100 000 in 1990 to 67.3 per 100 000 in 2021, with type 1 diabetes-related blindness and vision loss ASPR showing a modest decrease (from 1.8 to 1.7 per 100 000). The highest relative increase was recorded in the high SDI group (45.8%). For Type 1 diabetes, low-middle and low SDI groups exhibited more pronounced declines in associated ASPR. Increasing ASPR with advancing age was consistent across SDI groups though less pronounced for type 1 than type 2 diabetes. Unfavourable period and cohort effects were observed for type 2 but not type 1-related blindness and vision loss risk. High-middle SDI and middle SDI groups showed the most notable increase in period and cohort effect, whereas low-middle and low SDI groups experienced favourable period and cohort risks during the study duration. Conclusions: Substantially different trends were observed for ASPR, period and cohort effects in recent decades for type 1 versus type 2 diabetes across different SDI.
- Open Access
- 6 April 2026
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 15 (4) , 11
Mislabeling of Case-Control Studies in Ophthalmologic Literature: A Bibliometric Analysis
To characterize the prevalence and determinants of case-control study mislabeling in recent ophthalmologic journals. A bibliometric analysis was conducted on 386 articles self-declared as case-control or case-controlled studies, published from 2022 to 2023 across 95 PubMed-indexed ophthalmologic journals. Two blinded reviewers independently classified study designs using established epidemiological criteria and standardized the Level of Evidence per the Joanna Briggs Institute (2014) guidelines. Associations between mislabeling and bibliometric factors (Journal Citation Reports quartile, place of publication) were evaluated using logistic regression. A total of 273 articles (70.7%) were mislabeled. Reclassification revealed alterations in evidence hierarchies, with 49% exhibiting inflated level of evidence and 18% demonstrating under-reported level of evidence. Logistic regression revealed that articles published in Q1 journals had significantly lower odds of being mislabeled (odds ratio, 0.511; 95% confidence interval, 0.277-0.943) compared with Q4 journals. No significant association was found between mislabeling and the place of publication. There is pervasive mislabeling of study designs in ophthalmologic journals that distorts levels of evidence, necessitating standardized guidelines and validation tools. This study enhances the reliability of ophthalmologic evidence by providing a framework to identify and correct mislabeled study designs.
- 6 April 2026
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 15 (4) , 11
Open AccessMislabeling of Case-Control Studies in Ophthalmologic Literature: A Bibliometric Analysis
To characterize the prevalence and determinants of case-control study mislabeling in recent ophthalmologic journals. A bibliometric analysis was conducted on 386 articles self-declared as case-control or case-controlled studies, published from 2022 to 2023 across 95 PubMed-indexed ophthalmologic journals. Two blinded reviewers independently classified study designs using established epidemiological criteria and standardized the Level of Evidence per the Joanna Briggs Institute (2014) guidelines. Associations between mislabeling and bibliometric factors (Journal Citation Reports quartile, place of publication) were evaluated using logistic regression. A total of 273 articles (70.7%) were mislabeled. Reclassification revealed alterations in evidence hierarchies, with 49% exhibiting inflated level of evidence and 18% demonstrating under-reported level of evidence. Logistic regression revealed that articles published in Q1 journals had significantly lower odds of being mislabeled (odds ratio, 0.511; 95% confidence interval, 0.277-0.943) compared with Q4 journals. No significant association was found between mislabeling and the place of publication. There is pervasive mislabeling of study designs in ophthalmologic journals that distorts levels of evidence, necessitating standardized guidelines and validation tools. This study enhances the reliability of ophthalmologic evidence by providing a framework to identify and correct mislabeled study designs.
- 9 March 2026
- Published by Taylor & Francis in Current Eye Research
- Vol. 51 (6) , 621-630
Aniseikonia Tests: A Review of Current Measurement Methods
Aniseikonia, a perceptual asymmetry in ocular image size or shape, disrupts binocular vision and stereopsis. Aniseikonia testing is essential for quantifying visual dysfunction and improving prognosis. This review aims to evaluate advances in aniseikonia testing, with emphasis on clinical utility and methodological limitations. A narrative review was conducted to synthesize evidence on traditional and digital approaches to aniseikonia assessment, with attention to testing principles and clinical applications. Traditional afocal lens methods have been supplanted by digital innovations like the New Aniseikonia Test (NAT) and Aniseikonia Inspector version 3 (AI3), which enhance precision through patient-specific optical modeling and adaptive psychophysical protocols. These tools enable efficient quantification of global and meridional aniseikonia, with clinical studies linking measurements to retinal pathologies (epiretinal membranes, macular edema) and surgical outcomes (cataract extraction, retinal detachment repair). Clinical applications extend to patients undergoing retinal surgery and those with amblyopia or binocular vision disorders. However, current tests remain constrained by methodological inconsistencies, including variability in stimulus types (e.g., dichoptic shapes vs. red-green filters), testing distances, and scoring criteria, which limit cross-study comparability. The findings emphasize the importance of aniseikonia tests in clinical practice, which provide valuable insights into visual dysfunction and can aid in predicting treatment outcomes. Future efforts should prioritize the standardization of test parameters (luminance, contrast) and validation in diverse populations, particularly amblyopic and pediatric patients, to refine diagnostic thresholds. Emerging technologies such as tablets and cell phones will facilitate test administration and improve accessibility. Establishing consensus guidelines for clinical interpretation will enhance reliability in diagnosing and managing aniseikonia. By addressing these challenges, next-generation tests can better align theoretical accuracy with practical application, ultimately improving patient outcomes in conditions where binocular vision is compromised.
- 9 March 2026
- Published by Taylor & Francis in Current Eye Research
- Vol. 51 (6) , 621-630
Aniseikonia Tests: A Review of Current Measurement Methods
Aniseikonia, a perceptual asymmetry in ocular image size or shape, disrupts binocular vision and stereopsis. Aniseikonia testing is essential for quantifying visual dysfunction and improving prognosis. This review aims to evaluate advances in aniseikonia testing, with emphasis on clinical utility and methodological limitations. A narrative review was conducted to synthesize evidence on traditional and digital approaches to aniseikonia assessment, with attention to testing principles and clinical applications. Traditional afocal lens methods have been supplanted by digital innovations like the New Aniseikonia Test (NAT) and Aniseikonia Inspector version 3 (AI3), which enhance precision through patient-specific optical modeling and adaptive psychophysical protocols. These tools enable efficient quantification of global and meridional aniseikonia, with clinical studies linking measurements to retinal pathologies (epiretinal membranes, macular edema) and surgical outcomes (cataract extraction, retinal detachment repair). Clinical applications extend to patients undergoing retinal surgery and those with amblyopia or binocular vision disorders. However, current tests remain constrained by methodological inconsistencies, including variability in stimulus types (e.g., dichoptic shapes vs. red-green filters), testing distances, and scoring criteria, which limit cross-study comparability. The findings emphasize the importance of aniseikonia tests in clinical practice, which provide valuable insights into visual dysfunction and can aid in predicting treatment outcomes. Future efforts should prioritize the standardization of test parameters (luminance, contrast) and validation in diverse populations, particularly amblyopic and pediatric patients, to refine diagnostic thresholds. Emerging technologies such as tablets and cell phones will facilitate test administration and improve accessibility. Establishing consensus guidelines for clinical interpretation will enhance reliability in diagnosing and managing aniseikonia. By addressing these challenges, next-generation tests can better align theoretical accuracy with practical application, ultimately improving patient outcomes in conditions where binocular vision is compromised.
- Open Access
- 30 January 2026
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 15 (2) , 100294
Accuracy of self-refraction using a portable device based on badal optics, iREF, in children in southern China: A cross-sectional study
- 30 January 2026
- Published by Elsevier in Asia-Pacific Journal of Ophthalmology
- Vol. 15 (2) , 100294
Open AccessAccuracy of self-refraction using a portable device based on badal optics, iREF, in children in southern China: A cross-sectional study
- Open Access
- 25 February 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (4) , 100750
A Novel Bluetooth-Based Automated Flipper for Measuring Accommodative Facility: a Comparison with Conventional Manual Flipper
- 25 February 2025
- Published by Elsevier in Ophthalmology Science
- Vol. 5 (4) , 100750
Open AccessA Novel Bluetooth-Based Automated Flipper for Measuring Accommodative Facility: a Comparison with Conventional Manual Flipper
- Open Access
- 3 September 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (2) , 1420-1421
The "Finger-and-Fist" teaching model in functional anatomy of the extraocular muscles
- 3 September 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (2) , 1420-1421
Open AccessThe "Finger-and-Fist" teaching model in functional anatomy of the extraocular muscles
- 28 December 2023
- Published by Taylor & Francis in Current Eye Research
- Vol. 49 (4) , 417-424
Assessment of Peripapillary Retinal Nerve Fiber Layer Optical Density Ratios in Healthy Eyes Using Optical Coherence Tomography with Different Analytical Radii
- 28 December 2023
- Published by Taylor & Francis in Current Eye Research
- Vol. 49 (4) , 417-424
Assessment of Peripapillary Retinal Nerve Fiber Layer Optical Density Ratios in Healthy Eyes Using Optical Coherence Tomography with Different Analytical Radii
- 9 July 2023
- Published by BMJ in British Journal of Ophthalmology
- Vol. 108 (2) , 301-309
Persistence of severe global inequalities in the burden of blindness and vision loss from 1990 to 2019: findings from the Global Burden of Disease Study 2019
Aims To assess the global burden and economic inequalities in the distribution of blindness and vision loss between 1990 and 2019. Methods A secondary analysis of the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 2019. Data for disability-adjusted life-years (DALYs) due to blindness and vision loss were extracted from the GBD 2019. Data for gross domestic product per capita were extracted from the World Bank database. Slope index of inequality (SII) and concentration index were computed to assess absolute and relative cross-national health inequality, respectively. Results Countries with high, high-middle, middle, low-middle and low Socio-demographic Index (SDI) had decline of age-standardised DALY rate of 4.3%, 5.2%, 16.0%, 21.4% and 11.30% from 1990 to 2019, respectively. The poorest 50% of world citizens bore 59.0% and 66.2% of the burden of blindness and vision loss in 1990 and 2019, respectively. The absolute cross-national inequality (SII) fell from −303.5 (95% CI −370.8 to −236.2) in 1990 to −256.0 (95% CI −288.1 to −223.8) in 2019. The relative inequality (concentration index) for global blindness and vision loss remained essentially constant between 1991 (−0.197, 95% CI −0.234 to −0.160) and 2019 (−0.193, 95% CI −0.216 to −0.169). Conclusion Though countries with middle and low-middle SDI were the most successful in decreasing burden of blindness and vision loss, a high level of cross-national health inequality persisted over the past three decades. More attention must be paid to the elimination of avoidable blindness and vision loss in low-income and middle-income countries.
- 9 July 2023
- Published by BMJ in British Journal of Ophthalmology
- Vol. 108 (2) , 301-309
Persistence of severe global inequalities in the burden of blindness and vision loss from 1990 to 2019: findings from the Global Burden of Disease Study 2019
Aims To assess the global burden and economic inequalities in the distribution of blindness and vision loss between 1990 and 2019. Methods A secondary analysis of the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 2019. Data for disability-adjusted life-years (DALYs) due to blindness and vision loss were extracted from the GBD 2019. Data for gross domestic product per capita were extracted from the World Bank database. Slope index of inequality (SII) and concentration index were computed to assess absolute and relative cross-national health inequality, respectively. Results Countries with high, high-middle, middle, low-middle and low Socio-demographic Index (SDI) had decline of age-standardised DALY rate of 4.3%, 5.2%, 16.0%, 21.4% and 11.30% from 1990 to 2019, respectively. The poorest 50% of world citizens bore 59.0% and 66.2% of the burden of blindness and vision loss in 1990 and 2019, respectively. The absolute cross-national inequality (SII) fell from −303.5 (95% CI −370.8 to −236.2) in 1990 to −256.0 (95% CI −288.1 to −223.8) in 2019. The relative inequality (concentration index) for global blindness and vision loss remained essentially constant between 1991 (−0.197, 95% CI −0.234 to −0.160) and 2019 (−0.193, 95% CI −0.216 to −0.169). Conclusion Though countries with middle and low-middle SDI were the most successful in decreasing burden of blindness and vision loss, a high level of cross-national health inequality persisted over the past three decades. More attention must be paid to the elimination of avoidable blindness and vision loss in low-income and middle-income countries.
- Open Access
- 10 May 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Effect of school entrance age on myopia among primary schoolchildren using mixed-effect model: the Shantou Myopia Study (SMS) (Preprint)
BACKGROUND Few research about the relationship between the school entrance age and myopia in schoolchildren has been reported. OBJECTIVE To investigate the association between children's school entrance age and refractive status and prevalence of myopia in southern China. METHODS This Population-based Cross-sectional study was conducted during September 2020 to June 2021 in Shantou, southern China, enrolling all the primary schoolchildren in the city. The school entrance age was calculated as the months from the birth date to the entrance date, divided by 12. Non-cycloplegic refraction and uncorrected visual acuity test were conducted. Myopia was defined as a spherical equivalent refraction (SER)<-0.50D with an uncorrected distant visual acuity < Snellen20/20. We explored the association between the SER and the school entrance age, with the clustering effect within schools adjusted by the linear mixed-model. RESULTS We enrolled 410,080 primary schoolchildren, with the mean age of 9.8±1.6 years. The overall prevalence of myopia was 42.04%. The mean SER of myopic children was -2.15±1.70D. The mixed-effects model revealed a significant correlation between the school entrance age and the SER and the prevalence of myopia. One year later for school entrance age would independently result in a less myopic SER with 0.352D (standard error=0.016, P<0.001), and significantly decrease the prevalence of myopia (odds ratio=0.632, standard error=0.013219, P<0.001). Children born before September 1st had significantly more myopic SER than those born after September 1st (-1.77 vs -1.73, P<0.001) CONCLUSIONS Early school entrance, rather than age or prolonged exposure to schooling, was an independent risk factor of myopia. It is important to put forward some scientific and effective measures, preventing children from early exposure to task-heavy school life and near work.
- 10 May 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffect of school entrance age on myopia among primary schoolchildren using mixed-effect model: the Shantou Myopia Study (SMS) (Preprint)
BACKGROUND Few research about the relationship between the school entrance age and myopia in schoolchildren has been reported. OBJECTIVE To investigate the association between children's school entrance age and refractive status and prevalence of myopia in southern China. METHODS This Population-based Cross-sectional study was conducted during September 2020 to June 2021 in Shantou, southern China, enrolling all the primary schoolchildren in the city. The school entrance age was calculated as the months from the birth date to the entrance date, divided by 12. Non-cycloplegic refraction and uncorrected visual acuity test were conducted. Myopia was defined as a spherical equivalent refraction (SER)<-0.50D with an uncorrected distant visual acuity < Snellen20/20. We explored the association between the SER and the school entrance age, with the clustering effect within schools adjusted by the linear mixed-model. RESULTS We enrolled 410,080 primary schoolchildren, with the mean age of 9.8±1.6 years. The overall prevalence of myopia was 42.04%. The mean SER of myopic children was -2.15±1.70D. The mixed-effects model revealed a significant correlation between the school entrance age and the SER and the prevalence of myopia. One year later for school entrance age would independently result in a less myopic SER with 0.352D (standard error=0.016, P<0.001), and significantly decrease the prevalence of myopia (odds ratio=0.632, standard error=0.013219, P<0.001). Children born before September 1st had significantly more myopic SER than those born after September 1st (-1.77 vs -1.73, P<0.001) CONCLUSIONS Early school entrance, rather than age or prolonged exposure to schooling, was an independent risk factor of myopia. It is important to put forward some scientific and effective measures, preventing children from early exposure to task-heavy school life and near work.
- Open Access
- 10 February 2023
- Published by Taylor & Francis in Medical Education Online
- Vol. 28 (1) , 2176201
Smartphone ophthalmoscope as a tool in teaching direct ophthalmoscopy: a crossover randomized controlled trial
To evaluate the effectiveness of smartphone ophthalmoscope (SO) in teaching ophthalmoscopy, compared with direct ophthalmoscope (DO). In this cross-over study, 45 final-year medical students attending sessions at a single institution were randomly allocated to two groups (A and B). Both groups attended two training sessions. In the first session, Group A students were taught ophthalmoscopy using DO and Group B students using SO. In the second session, the training sessions were crossed over. A series of eye models with 10 letters placed on the inner surface were designed to assess the students’ skill on ophthalmoscopy. Students performed ophthalmoscopy on the eye models, recorded their findings, and completed a questionnaire of feedback on DO and SO. The main outcome measure was the score of ophthalmoscopy, assessed by the student correctly recording each letter (score 1 for each letter). For Group A, the mean score of ophthalmoscopy on the eye model using DO and SO was 3.9±2.4 and 8.2±2.2, respectively. For Group B, the mean score of ophthalmoscopy on the eye model using SO and DO 8.7±1.8 and 5.7±3.5 . Students scored significantly higher in ophthalmoscopy when using SO than DO (PP=0.004). Students’ performance of ophthalmoscopy was better when SO was used compared with DO. The use of SO as an adjunctive tool is recommended to improve the effectiveness of teaching ophthalmoscopy.
- 10 February 2023
- Published by Taylor & Francis in Medical Education Online
- Vol. 28 (1) , 2176201
Open AccessSmartphone ophthalmoscope as a tool in teaching direct ophthalmoscopy: a crossover randomized controlled trial
To evaluate the effectiveness of smartphone ophthalmoscope (SO) in teaching ophthalmoscopy, compared with direct ophthalmoscope (DO). In this cross-over study, 45 final-year medical students attending sessions at a single institution were randomly allocated to two groups (A and B). Both groups attended two training sessions. In the first session, Group A students were taught ophthalmoscopy using DO and Group B students using SO. In the second session, the training sessions were crossed over. A series of eye models with 10 letters placed on the inner surface were designed to assess the students’ skill on ophthalmoscopy. Students performed ophthalmoscopy on the eye models, recorded their findings, and completed a questionnaire of feedback on DO and SO. The main outcome measure was the score of ophthalmoscopy, assessed by the student correctly recording each letter (score 1 for each letter). For Group A, the mean score of ophthalmoscopy on the eye model using DO and SO was 3.9±2.4 and 8.2±2.2, respectively. For Group B, the mean score of ophthalmoscopy on the eye model using SO and DO 8.7±1.8 and 5.7±3.5 . Students scored significantly higher in ophthalmoscopy when using SO than DO (PP=0.004). Students’ performance of ophthalmoscopy was better when SO was used compared with DO. The use of SO as an adjunctive tool is recommended to improve the effectiveness of teaching ophthalmoscopy.